| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-775 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_954a337839abb3ecab9a14ac32bf2246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94ec34a0aa8873f69feee1cea1ceee5c |
| publicationDate |
2004-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004198656-A1 |
| titleOfInvention |
Methods of screening molecules that are used to prevent cardiovascular diseases |
| abstract |
The invention relates to compositions and methods for screening molecules that are used for the prevention or treatment of metabolic syndrome, cardiovascular diseases and/or atherosclerosis. In particular, the invention relates to methods and kits for screening compounds based on determining the effect of test compounds on the activity of a novel protein which is similar to apolipoprotein AIV. The invention also relates to compositions and methods for reducing the concentration of triglycerides and/or reducing the concentration or the expression of apolipoprotein CIII (apo CIII) and/or reducing the concentration of VLDL and/or increasing the activity of LpL and/or of HL and/or for increasing reverse cholesterol transport. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007099242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7972802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460889-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11647776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173136-B2 |
| priorityDate |
2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |